INSIDER · CIK 1672659
Rodman David Malcom
Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$59KSold on the market
1Companies
Aug 12, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 202619:33 | Aug 10, 2026 | MLYSMineralys Therapeutics, Inc. | Chief Medical Officer | S · Sell10b5-1 | $27.09 | −2,170 | 51,384 | -4% | −$59K | ||
| Aug 12, 202619:33 | Aug 10, 2026 | MLYSMineralys Therapeutics, Inc. | Chief Medical Officer | M · Exercise10b5-1 | $16.00 | +2,170 | 53,554 | +4% | $35K |